BACKGROUND: The objectives of this study were to determine effects of severe traumatic brain injury (TBI) on cerebrospinal fluid (CSF) concentrations of myelin basic protein (MBP) and to assess relationships between clinical variables and CSF MBP concentrations. METHODS: We measured serial CSF MBP concentrations in children enrolled in a randomized controlled trial evaluating therapeutic hypothermia (TH) after severe pediatric TBI. Control CSF was obtained from children evaluated, but found not to be having CNS infection. Generalized estimating equation models and Wilcoxon Rank-Sum test were used for comparisons of MBP concentrations. RESULTS: There were 27 TBI cases and 57 controls. Overall mean (± SEM) TBI case MBP concentrations for 5 days after injury were markedly greater than controls (50.49 ± 6.97 vs. 0.11 ± 0.01 ng/ml, p < 0.01). Mean MBP concentrations were lower in TBI patients <1 year versus >1 year (9.18 ± 1.67 vs. 60.22 ± 8.26 ng/ml, p = 0.03), as well as in cases with abusive head trauma (AHT) versus non-abusive TBI (14.46 ± 3.15 vs. 61.17 ± 8.65 ng/ml, p = 0.03). TH did not affect MBP concentrations. CONCLUSIONS:Mean CSF MBP increases markedly after severe pediatric TBI, but is not affected by TH. Infancy and AHT are associated with low MBP concentrations, suggesting that age-dependent myelination influences MBP concentrations after injury. Given the magnitude of MBP increases, axonal injury likely represents an important therapeutic target in pediatric TBI.
RCT Entities:
BACKGROUND: The objectives of this study were to determine effects of severe traumatic brain injury (TBI) on cerebrospinal fluid (CSF) concentrations of myelin basic protein (MBP) and to assess relationships between clinical variables and CSF MBP concentrations. METHODS: We measured serial CSF MBP concentrations in children enrolled in a randomized controlled trial evaluating therapeutic hypothermia (TH) after severe pediatric TBI. Control CSF was obtained from children evaluated, but found not to be having CNS infection. Generalized estimating equation models and Wilcoxon Rank-Sum test were used for comparisons of MBP concentrations. RESULTS: There were 27 TBI cases and 57 controls. Overall mean (± SEM) TBI case MBP concentrations for 5 days after injury were markedly greater than controls (50.49 ± 6.97 vs. 0.11 ± 0.01 ng/ml, p < 0.01). Mean MBP concentrations were lower in TBI patients <1 year versus >1 year (9.18 ± 1.67 vs. 60.22 ± 8.26 ng/ml, p = 0.03), as well as in cases with abusive head trauma (AHT) versus non-abusive TBI (14.46 ± 3.15 vs. 61.17 ± 8.65 ng/ml, p = 0.03). TH did not affect MBP concentrations. CONCLUSIONS: Mean CSF MBP increases markedly after severe pediatric TBI, but is not affected by TH. Infancy and AHT are associated with low MBP concentrations, suggesting that age-dependent myelination influences MBP concentrations after injury. Given the magnitude of MBP increases, axonal injury likely represents an important therapeutic target in pediatric TBI.
Authors: Lina Du; Hülya Bayir; Yichen Lai; Xiaopeng Zhang; Patrick M Kochanek; Simon C Watkins; Steven H Graham; Robert S B Clark Journal: J Biol Chem Date: 2004-07-01 Impact factor: 5.157
Authors: P David Adelson; John Ragheb; Paul Kanev; Douglas Brockmeyer; Sue R Beers; S Danielle Brown; Laura D Cassidy; Yuefang Chang; Harvey Levin Journal: Neurosurgery Date: 2005-04 Impact factor: 4.654
Authors: Hülya Bayir; Donald W Marion; Ava M Puccio; Stephen R Wisniewski; Keri L Janesko; Robert S B Clark; Patrick M Kochanek Journal: J Neurotrauma Date: 2004-01 Impact factor: 5.269
Authors: Teresa M Evans; Holly Van Remmen; Anjali Purkar; Swetha Mahesula; J Al Gelfond; Marian Sabia; Wenbo Qi; Ai-Ling Lin; Carlos A Jaramillo; William E Haskins Journal: Transl Proteom Date: 2014-06-01
Authors: Patrick M Kochanek; Travis C Jackson; Nikki Miller Ferguson; Shaun W Carlson; Dennis W Simon; Erik C Brockman; Jing Ji; Hülya Bayır; Samuel M Poloyac; Amy K Wagner; Anthony E Kline; Philip E Empey; Robert S B Clark; Edwin K Jackson; C Edward Dixon Journal: Semin Neurol Date: 2015-02-25 Impact factor: 3.420
Authors: Ericka L Fink; Rachel P Berger; Robert S B Clark; Robert S Watson; Derek C Angus; Rudolph Richichi; Ashok Panigrahy; Clifton W Callaway; Michael J Bell; Patrick M Kochanek Journal: Crit Care Med Date: 2014-03 Impact factor: 7.598
Authors: Benjamin Ondruschka; Michael Bohnert; Simone Bohnert; Christoph Wirth; Werner Schmitz; Stefanie Trella; Camelia-Maria Monoranu Journal: Int J Legal Med Date: 2021-04-24 Impact factor: 2.686